A group of white blood cells known as B cells, which play a key role in the human immune response, need a protein-targeting signal called mannose 6-phosphate (M6P) in order to
proliferate1,
differentiate2, and present immune cell-activating antigens, according to a study in The Journal of Cell Biology. Immune cells slice up antigens in organelles called lysosomes and attach the fragments to complexes that display them on the cell surface in order for these peptides to
bind3 and
activate4 other immune cells. To ensure that they can cut up the antigens, cells
steer5 newly made
enzymes6 to lysosomes by tagging them with M6P
molecules7. In the rare disease mucolipidosis II, patients can't synthesize M6P, and their lysosomes fill up with undigested
molecular8 junk known as storage material.
To find out how loss of M6P affects different kinds of immune cells, researchers in Germany used mutant mice that
mimic9 symptoms of mucolipidosis II patients. The animals' B cells were abnormal. Their lysosomes
bulged10 with storage material, and they were poor at dismembering antigens and breaking down a protein that prevents the presentation of antigen fragments. The researchers also found that key processes related to maturation, proliferation, and
differentiation11 were
impaired12 in B cells from the mutant mice, and the cells were
defective13 and produced fewer antibodies than normal. Importantly, they confirmed that B cells from patients with the disease present similar defects in antibody synthesis.
However, the authors discovered that other types of immune cells in these mice, such as dendritic cells and T cells, weren't as
severely14 affected15. The findings therefore indicate that B cells are more dependent on M6P than are other immune cells. The enzymes in these other cells presumably reach the lysosome through M6P-independent pathways. In addition, these data may explain why patients with mucolipidosis II suffer from recurrent infections.